Margaret von Mehren
Chief, Division of Sarcoma Medical Oncology · Temple University Hospital
Credentials: · · ·
History
PresentDivision of Sarcoma Medical Oncology · Temple University Hospital
- Present
Department of Hematology/Oncology · Temple University Hospital
- Present
Clinical Research · Temple University Hospital
- 1992–1994
Medical Oncology
- 1989–1992
Internal Medicine
1985–1989
1981–1985
Research
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
New England Journal of Medicine · 2002 · 3,431 citations
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
Journal of Clinical Oncology · 2003 · 1,800 citations
The Lancet · 2013 · 1,110 citations
43 papers
39 papers
- MH
38 papers
23 papers
- SS
23 papers
- RM
22 papers
21 papers
- CB
20 papers
Grants
- 1997–2030
Comprehensive Cancer Center Program at Fox Chase
National Cancer Institute · P30
Project lead · $3.1M · Research Inst of Fox Chase Can Ctr
- 2023–2028
Elucidating the Critical Role of Wee1 in GIST
National Cancer Institute · R01
PI · $1.7M · Research Inst of Fox Chase Can Ctr
- 2011–2015
Preliminary Evaluation of FDG-PET with Anti-IGF-1R Targeted Therapy in GISTs
National Cancer Institute · R21
Contact PI · $532K · Research Inst of Fox Chase Can Ctr
- 2004–2015
The Molecular Actions of Imatinib Mesylate in GISTs
National Cancer Institute · R01
PI · $2M · University of Kansas Medical Center
Clinical trials
- 2022–2027